All In Biotech

Drug Trial Radar · NCT04708782

Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-1)

Last checked: Nov 19, 2026Latest source record: May 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 598 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

598

Actual

Start

Jun 1, 2021

Primary completion

Feb 2, 2026

Study completion Feb 2, 2026

Sponsor

Lead sponsor
United TherapeuticsIndustry
Sponsor type
Industry
First posted
Jan 14, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from baseline to Week 52.

Conditions

  • Idiopathic Pulmonary Fibrosis
  • Interstitial Lung Disease

Interventions

  • PlaceboDrug

    Placebo administered QID

  • Inhaled TreprostinilDrug

    Inhaled treprostinil (6 mcg/breath) administered QID

  • Treprostinil Ultrasonic NebulizerDevice

    Treprostinil ultrasonic nebulizer which emits a dose of approximately 6 mcg per breath.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Absolute FVC from Baseline to Week 52Time frame: Baseline to Week 52

Locations

98 sites in 3 countries. Site status is shown where the registry gives one.

  • The University of Alabama at Birmingham

    Birmingham, Alabama

  • Banner University Medical Center-Phoenix

    Phoenix, Arizona

  • Arizona Pulmonary Specialists, Ltd.

    Phoenix, Arizona

  • St. Joseph's Hospital and Medical Center - Norton Thoracic Institute

    Phoenix, Arizona

  • University of Arizona

    Tucson, Arizona

  • UC San Diego Health

    La Jolla, California

  • David Geffen School of Medicine at UCLA

    Los Angeles, California

  • NewportNativeMD, Inc

    Newport Beach, California

  • University of California, Irvine

    Orange, California

  • Palmtree Clinical Research, Inc.

    Palm Springs, California

  • UC Davis Health Medical Center

    Sacramento, California

  • University of California - San Francisco

    San Francisco, California

  • Stanford University Medical Center

    Stanford, California

  • National Jewish Health

    Denver, Colorado

  • St. Francis Sleep Allergy & Lung Institute

    Clearwater, Florida

  • University of Florida Health at Shands

    Gainesville, Florida

  • Ascension St. Vincent's

    Jacksonville, Florida

  • University of Florida

    Jacksonville, Florida

  • Mayo Clinic Florida

    Jacksonville, Florida

  • Pulmonary Disease Specialists, PA d/b/a PDS Research

    Kissimmee, Florida

  • Central Florida Pulmonary Group, PA

    Orlando, Florida

  • Coastal Pulmonary & Critical Care PLC

    St. Petersburg, Florida

  • University of South Florida Health

    Tampa, Florida

  • Cleveland Clinic Florida

    Weston, Florida

  • Piedmont Healthcare Atlanta

    Atlanta, Georgia

  • Emory University Hospital

    Atlanta, Georgia

  • The Queen's Medical Center

    Honolulu, Hawaii

  • Northwestern Memorial Hospital

    Chicago, Illinois

  • Rush University Medical Center Outpatient Pulmonary Clinic

    Chicago, Illinois

  • Loyola University Medical Center

    Maywood, Illinois

  • Community Health Network

    Indianapolis, Indiana

  • The University of Kansas Medical Center

    Kansas City, Kansas

  • Norton Pulmonary Specialists

    Louisville, Kentucky

  • University of Louisville

    Louisville, Kentucky

  • LSU Health Sciences Center New Orleans

    New Orleans, Louisiana

  • Tulane University Medical Center

    New Orleans, Louisiana

  • LSU Health Science Center Shreveport

    Shreveport, Louisiana

  • Johns Hopkins Asthma & Allergy Center

    Baltimore, Maryland

  • Adventist Healthcare White Oak Medical CEnter

    Silver Spring, Maryland

  • Tufts Medical Center

    Boston, Massachusetts

Showing 40 of 98 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.